Anidulafungin: When and how? The clinician's view

Jomy George, Annette C. Reboli

    Research output: Contribution to journalReview articlepeer-review

    11 Scopus citations

    Abstract

    Anidulafungin is the newest addition to the antifungal arsenal. It possesses fungicidal activity against Candida spp., including isolates that are azole and polyene resistant. In addition, it is fungistatic against Aspergillus spp. Anidulafungin is unique in that it possesses no clinically relevant drug interactions and does not require dosage adjustment in renal or hepatic impairment. Anidulafungin was well tolerated in clinical trials and its clinical efficacy has been demonstrated in the treatment of candidemia and other forms of candidiasis.

    Original languageEnglish (US)
    Pages (from-to)36-44
    Number of pages9
    JournalMycoses
    Volume55
    Issue number1
    DOIs
    StatePublished - Jan 1 2012

    All Science Journal Classification (ASJC) codes

    • Dermatology
    • Infectious Diseases

    Fingerprint

    Dive into the research topics of 'Anidulafungin: When and how? The clinician's view'. Together they form a unique fingerprint.

    Cite this